Grant: Engage Grants Program
University of British Columbia
$25,000.00
Harnessing the benefits of continuous crystallization to precisely control particular size distribution of active pharmaceutical ingredients
EF 2017-18
Résumé
Control of crystallite particle size distribution is essential in the manufacturing of pharmaceutical dosageforms. In particular, obtaining a narrow size distribution is essential to enable new sustained release technologydeveloped by Eupraxia pharmaceuticals. The present workflow presents a significant barrier to scale up andmanufacturing of a novel anti-inflammatory therapy. New techniques designed by the Hein lab, whichleverages automation and in situ monitoring technology, will help to identify optimal crystallization conditionsto achieve a narrow and controlled particle size distribution for the active pharmaceutical ingredient. Inaddition, the Hein lab will investigate adapting the optimized crystallization process into a continuouscrystallization workflow, making the final manufacturing stage robust and very efficient.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
508663-2017
Name nom
Hein, Jason
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1806
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Separation processes
Research subject fr
Procédés de séparation
Partie
1
Nb partie
1
Application title
Harnessing the benefits of continuous crystallization to precisely control particular size
distribution of active pharmaceutical ingredients
Keyword
NSERC
Application summary
Control of crystallite particle size distribution is essential in the manufacturing of pharmaceutical dosageforms. In particular, obtaining a narrow size distribution is essential to enable new sustained release technologydeveloped by Eupraxia pharmaceuticals. The present workflow presents a significant barrier to scale up andmanufacturing of a novel anti-inflammatory therapy. New techniques designed by the Hein lab, whichleverages automation and in situ monitoring technology, will help to identify optimal crystallization conditionsto achieve a narrow and controlled particle size distribution for the active pharmaceutical ingredient. Inaddition, the Hein lab will investigate adapting the optimized crystallization process into a continuouscrystallization workflow, making the final manufacturing stage robust and very efficient.